Treatment of hypertriglyceridemia

被引：6

作者：

Capell W.H. ^{[1
]}

Eckel R.H. ^{[1
]}

机构：

[1] University of Colorado, Health Sciences Center, Division of Endocrinology, Metabolism and Diabetes, Aurora, CO 80045

来源：

Current Diabetes Reports | 2006年 / 6卷 / 3期

关键词：

D O I：

10.1007/s11892-006-0040-9

中图分类号：

学科分类号：

摘要：

Hypertriglyceridemia is a disorder commonly encountered in clinical practice. Treatment of this condition aims to prevent the major complications of hypertriglyceridemia, which differ depending on whether triglyceride elevations are moderate or severe. This review discusses the pathophysiology and clinical consequences of hypertriglyceridemia and outlines treatment approaches based on the degree of triglyceride elevation. Special consideration is given to clinical trials using medications that primarily target triglycerides. Copyright © 2006 by Current Science Inc.

引用

页码：230 / 240

页数：10

共 52 条

[1]

Ford E.S., Giles W.H., Dietz W.H., Prevalence of the metabolic syndrome among US adults: Findings from the third National Health and Nutrition Examination Survey, JAMA, 287, pp. 356-359, (2002)

[2]

Carroll M.D., Lacher D.A., Sorlie P.D., Et al., Trends in serum lipids and lipoproteins of adults, 1960-2002, JAMA, 294, pp. 1773-1781, (2005)

[3]

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III), JAMA, 285, pp. 2486-2497, (2001)

[4]

Brunzell J.D., Schrott H.C., Motulsky A.G., Et al., Myocardial infarction in the familial forms of hypertriglyceridemia, Metabolism, 25, pp. 313-320, (1976)

[5]

Malekzadeh S., Dressler F.A., Hoeg J.M., Et al., Left atrial endocardial lipid deposits and absent to minimal arterial lipid deposits in familial hyperchylomicronemia, Am J Cardiol, 67, pp. 1431-1434, (1991)

[6]

Hokanson J.E., Austin M.A., Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: A meta-analysis of population-based prospective studies, J Cardiovasc Risk, 3, pp. 213-219, (1996)

[7]

Jeppesen J., Hein H.O., Suadicani P., Et al., Triglyceride concentration and ischemic heart disease: An eight-year follow-up in the Copenhagen Male Study, Circulation, 97, pp. 1029-1036, (1998)

[8]

Yarnell J.W., Patterson C.C., Sweetnam P.M., Et al., Do total and high density lipoprotein cholesterol and triglycerides act independently in the prediction of ischemic heart disease? Ten-year follow-up of Caerphilly and Speedwell Cohorts, Arterioscler Thromb Vasc Biol, 21, pp. 1340-1345, (2001)

[9]

Hopkins P.N., Wu L.L., Hunt S.C., Et al., Plasma triglycerides and type III hyperlipidemia are independently associated with premature familial coronary artery disease, J Am Coll Cardiol, 45, pp. 1003-1012, (2005)

[10]

Hokanson J.E., Hypertriglyceridemia and risk of coronary heart disease, Curr Cardiol Rep, 4, pp. 488-493, (2002)

← 1 2 3 4 5 6 →